Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA079512-02
Application #
6376940
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Cole, John S
Project Start
2000-04-13
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
2
Fiscal Year
2001
Total Cost
$340,197
Indirect Cost

  Institution

Name
Thomas Jefferson University
Department
Pathology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107

  Publications

Chichester, Jessica A; Feitelson, Mark A; Calkins, Catherine E (2006) Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells. Immunology 118:438-48
Chichester, Jessica A; Feitelson, Mark A; Calkins, Catherine E (2006) Different response requirements for IFNgamma production in ELISPOT assays by CD4+ T cells from mice early and late after immunization. J Immunol Methods 309:99-107
Feitelson, Mark A; Larkin, Jonathan D; Schinazi, Raymond F (2004) Hepatitis B virus transgenic severe combined immunodeficient mouse model of acute and chronic liver disease. Methods Mol Med 96:269-87
Chen, Huachun; Pai, S Balakrishna; Hurwitz, Selwyn J et al. (2003) Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine. Antimicrob Agents Chemother 47:1922-8
Feitelson, Mark A; Sun, Bill; Satiroglu Tufan, N Lale et al. (2002) Genetic mechanisms of hepatocarcinogenesis. Oncogene 21:2593-604
Larkin, J; Clayton, M M; Liu, J et al. (2001) Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology 34:792-7
Feitelson, M A; Larkin, J D (2001) New animal models of hepatitis B and C. ILAR J 42:127-38